The Latest Dose

Ep. 11: Spreading Joy to Those in Need – the Role of Therapy Dogs in a Clinical Setting

Research shows that animals can improve the mental, physical, and emotional wellbeing of their human companions. From this strong bond comes the concept of therapy animals, or in this case, therapy dogs.
But what is a therapy dog, and how are they being used today?
In this episode, Kathy speaks with Children's Hospital Los Angeles and the Alliance of Therapy Dogs about their therapy dog programs, what it takes to become a volunteer, how dog therapy works, and more.
 

Ep. 10: Solving Problems in Clinical Trials with Innovation

What is the role of innovation in clinical trials and why is it important? In this episode, Kathy speaks with Craig Serra, who works in clinical technology and innovation at Novartis, about different types of innovation and how they're used in the pharma industry.

Ep. 9: The Prix Galien – Honoring Pharmaceutical Research and Development for 50 Years

Every year, the brightest minds in pharmaceuticals and clinical innovation put on their best black-tie attire for the life science industry’s biggest event, the Prix Galien. In this episode, you’ll learn about the history of the Prix Galien Awards, why it is considered the “Nobel Prize” for pharmaceutical research and development, and find out the new additions to its program from its chair and co-chair, Bruno Cohen and Dr. Michael Rosenblatt.

Ep. 8: Embracing the Future of Decentralized Trials and Remote Visits for Site Staff and Patients

The pandemic heavily disrupted clinical trials, pushing us to rethink how we conduct clinical research. In this episode, Kathy invites Casey Orvin, SVP of pharmaceutics relationships at StudyKIK and honorary president of SCRS to talk about the future of decentralized trials and remote visits from the patient and site perspective.
 
 

Ep. 7: The Role of AI, Automation, and Touchless Case Processing in Patient Safety

In episode seven of The Latest Dose, our host Kathy Vandebelt invites two of Oracle’s safety experts, Vice President of Safety Product Strategy, Bruce Palsulich, and Senior Director of Safety Strategy, Michael Braun-Boghos, to explore areas in pharmacovigilance where AI, automation, and touchless case processing are having a significant and positive impact on managing patient safety.
 

Ep. 6: Embracing Biometric Monitoring Technologies and Digital Measurement in Clinical Research

In this episode, host Kathy Vandebelt discusses how to get comfortable with the use of mobile technologies in clinical trials with our guest, Jennifer GoldSack. Jen serves as the Executive Director of the Digital Medicine Society (DiMe). She was also an Olympic athlete, and ties in her experience in the Olympics with the topic at hand – biometric monitoring.

Ep. 5: Thanking the Clinical Trial Patient and Giving Back for the Greater Good

In this episode, our host Kathy Vandebelt brings back Greater Gift and PopUp Star Founder, Jennifer Byrne, to talk this time specifically about the importance of giving back to clinical trial participants. In this interview, Jennifer dives into what Greater Gift is, her motivation for founding it, why it’s important, and what they do to thank participants and other clinical research stakeholders.

Ep. 4: Celebrating Clinical Trials Day and Bringing Awareness to Clinical Research

For Clinical Trials Day, we want to shine a light on the patients and people who bring awareness to clinical research. To do this, Kathy Vandebelt interviews two industry veterans, Greater Gift and PopUp Star Founder Jennifer Bryne, and Oracle Health Sciences’ Senior VP and General Manager Steve Rosenberg, about their personal experiences with clinical research, the history of Clinical Trials Day, what PopUp Star is, and how it's bringing awareness to clinical research.

Ep. 3: Considering the Patient & Improving the Clinical Research Ecosystem

Kathy Vandebelt speaks with Joe Kim, Eli Lilly & Company’s Sr. Advisor, Digital Health Office, and host of Lilly’s podcast Elixir Factor, which explores the factors that inspire bold advances in science. He aims to improve the capabilities for one of humankind's biggest social issues - the development of new medicine. Hear Joe’s opinions on approaches, initiatives, & technology to make clinical research more patient-friendly.

Ep. 2: Unifying the Old and New – How “Virtual” Components are Changing Clinical Trials

In this episode, Host Kathy Vandebelt discusses decentralized trials with Dylan Rosser, Executive Director of Global Development Operations at Amgen. Dylan brings to light the various virtual components that are used and can be stitched together in a trial. He also talks about the importance of the patient in clinical research, and highlights the benefits decentralized trials can bring to them.